These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 26962218)

  • 41. Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Primates Neutralize Primary Human Immunodeficiency Viruses (HIV-1) Sensitized by CD4-Mimetic Compounds.
    Madani N; Princiotto AM; Easterhoff D; Bradley T; Luo K; Williams WB; Liao HX; Moody MA; Phad GE; Vázquez Bernat N; Melillo B; Santra S; Smith AB; Karlsson Hedestam GB; Haynes B; Sodroski J
    J Virol; 2016 May; 90(10):5031-5046. PubMed ID: 26962221
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Innate protection against intrarectal SIV acquisition by a live SHIV vaccine.
    Sui Y; Meyer TJ; Fennessey CM; Keele BF; Dadkhah K; Ma C; LaBranche CC; Breed MW; Kramer JA; Li J; Howe SE; Ferrari G; Williams LD; Cam M; Kelly MC; Shen X; Tomaras GD; Montefiori D; Greten TF; Miller CJ; Berzofsky JA
    JCI Insight; 2024 May; 9(12):. PubMed ID: 38912579
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD8+ cells and small viral reservoirs facilitate post-ART control of SIV replication in M3+ Mauritian cynomolgus macaques initiated on ART two weeks post-infection.
    Harwood OE; Matschke LM; Moriarty RV; Balgeman AJ; Weaver AJ; Ellis-Connell AL; Weiler AM; Winchester LC; Fletcher CV; Friedrich TC; Keele BF; O'Connor DH; Lang JD; Reynolds MR; O'Connor SL
    PLoS Pathog; 2023 Sep; 19(9):e1011676. PubMed ID: 37747933
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD8+ cells and small viral reservoirs facilitate post-ART control of SIV in Mauritian cynomolgus macaques.
    Harwood OE; Matschke LM; Moriarty RV; Balgeman AJ; Weaver AJ; Ellis-Connell AL; Weiler AM; Winchester LC; Fletcher CV; Friedrich TC; Keele BF; O'Connor DH; Lang JD; Reynolds MR; O'Connor SL
    bioRxiv; 2023 Mar; ():. PubMed ID: 36909458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-15 Superagonist N-803 Enhances IFN-γ Production of MAIT Cells in SIV
    Ellis-Connell AL; Balgeman AJ; Kannal NM; Hansen Chaimson K; Batchenkova A; Safrit JT; O'Connor SL
    Infect Immun; 2022 Oct; 90(10):e0025922. PubMed ID: 36190256
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oral Vaccination Approaches for Anti-SHIV Immunity.
    Velarde de la Cruz E; Wang L; Bose D; Gangadhara S; Wilson RL; Amara RR; Kozlowski PA; Aldovini A
    Front Immunol; 2021; 12():702705. PubMed ID: 34234789
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Does Mucosal B1 Activation Result in the Accumulation of Peak IgM During Chronic Intrarectal SIVmac239 Exposure to Protect Chinese-Origin Rhesus Macaques From Disease Progression?
    Cong Z; Tong L; Wang Y; Su A; Chen T; Wei Q; Xue J; Qin C
    Front Microbiol; 2020; 11():357. PubMed ID: 32265850
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early HIV infection predictions: role of viral replication errors.
    Conway JM; Perelson AS
    SIAM J Appl Math; 2018; 78(4):1863-1890. PubMed ID: 31231142
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CD8β Depletion Does Not Prevent Control of Viral Replication or Protection from Challenge in Macaques Chronically Infected with a Live Attenuated Simian Immunodeficiency Virus.
    Sutton MS; Ellis-Connell A; Balgeman AJ; Barry G; Weiler AM; Hetzel SJ; Zhou Y; Lau-Kilby AW; Mason RD; Biris KK; Mascola JR; Sullivan NJ; Roederer M; Friedrich TC; O'Connor SL
    J Virol; 2019 Aug; 93(15):. PubMed ID: 31092584
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.
    Tsukamoto T
    Pharmaceutics; 2019 Mar; 11(3):. PubMed ID: 30862061
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of major histocompatibility complex-related molecule 1 sequence variants in non-human primates.
    Ellis-Connell AL; Kannal NM; Balgeman AJ; O'Connor SL
    Immunogenetics; 2019 Feb; 71(2):109-121. PubMed ID: 30353260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute-Phase CD4
    Sutton MS; Ellis-Connell A; Moriarty RV; Balgeman AJ; Gellerup D; Barry G; Weiler AM; Friedrich TC; O'Connor SL
    J Virol; 2018 Nov; 92(21):. PubMed ID: 30111562
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Breakthrough of SIV strain smE660 challenge in SIV strain mac239-vaccinated rhesus macaques despite potent autologous neutralizing antibody responses.
    Burton SL; Kilgore KM; Smith SA; Reddy S; Hunter E; Robinson HL; Silvestri G; Amara RR; Derdeyn CA
    Proc Natl Acad Sci U S A; 2015 Aug; 112(34):10780-5. PubMed ID: 26261312
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Both mucosal and systemic routes of immunization with the live, attenuated NYVAC/simian immunodeficiency virus SIV(gpe) recombinant vaccine result in gag-specific CD8(+) T-cell responses in mucosal tissues of macaques.
    Stevceva L; Alvarez X; Lackner AA; Tryniszewska E; Kelsall B; Nacsa J; Tartaglia J; Strober W; Franchini G
    J Virol; 2002 Nov; 76(22):11659-76. PubMed ID: 12388726
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mechanisms of protection against simian immunodeficiency virus infection.
    Johnson RP
    Vaccine; 2002 May; 20(15):1985-7. PubMed ID: 11983259
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Simian and feline immunodeficiency viruses: animal lentivirus models for evaluation of AIDS vaccines and antiviral agents.
    Gardner MB
    Antiviral Res; 1991 May; 15(4):267-86. PubMed ID: 1659310
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vaccination with Live Attenuated Simian Immunodeficiency Virus (SIV) Protects from Mucosal, but Not Necessarily Intravenous, Challenge with a Minimally Heterologous SIV.
    Sutton MS; Burns CM; Weiler AM; Balgeman AJ; Braasch A; Lehrer-Brey G; Friedrich TC; O'Connor SL
    J Virol; 2016 Jun; 90(12):5541-5548. PubMed ID: 26962218
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simian-human immunodeficiency virus SHIV89.6-induced protection against intravaginal challenge with pathogenic SIVmac239 is independent of the route of immunization and is associated with a combination of cytotoxic T-lymphocyte and alpha interferon responses.
    Abel K; Compton L; Rourke T; Montefiori D; Lu D; Rothaeusler K; Fritts L; Bost K; Miller CJ
    J Virol; 2003 Mar; 77(5):3099-118. PubMed ID: 12584336
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.